The Commonwealth Medical College - unique in many ways

First Clinical Research Study for The Commonwealth Medical College Receives Visit from the National Institute of Health Principal Investigator

Wednesday, February 04, 2020

Enrique Schisterman, PhD from the National Institute of Health in Bethesda Maryland will visit the site of the first clinical research study from The Commonwealth Medical College on Thursday, February 12, 2020.

Dr. Schisterman is the principal investigator of the EAGeR (Effects of Aspirin in Gestation and Reproduction) Study at the medical school. The study will evaluate the effects of the use of low dose aspirin compared to placebo in women who have had a pregnancy loss sometime in the past. This is a scientific study to determine if the treatment is effective. It is a national multi-centered, clinical trial study. The new medical school is partnering with the University of Buffalo, The University of Utah and The University of Haifa and The National Institute of Child Health and Human Development. The EAGeR Study is being conducted by a team of investigators at The Commonwealth Medical College in collaboration with Physicians Health Alliance at Moses Taylor Hospital.

“We are extremely excited about this important visit from Dr. Schisterman to the first research TCMC project being conducted in our local communities. We have already enrolled a few women into the study and they have been fantastic in their support for this project. We look forward to reaching our goal of enrolling 300 participants over the next three years from this region,” stated Anne Sweeney, PhD, Professor of Epidemiology.

Enrique Schisterman, PhD, is an Investigator who was recruited to the Epidemiology Branch in March 2002, for his expertise in epidemiologic methods. He earned his PhD from the State University of New York, Buffalo. His current research interest focuses on exposure assessment, with emphasis on the use of biomarkers. Dr. Schisterman has a long-standing interest in issues related to oxidative stress and its impact on general health, and particularly as it relates to women's health (i.e., endometriosis, infertility, and menstrual cycle function). Dr. Schisterman has worked to develop new analytical tools that are closely tied to etiological questions.

The Commonwealth Medical College has a goal of having a highly active research program that is based on the needs of its regional population. The College expects its research program to contribute to the local economic development via collaborations with businesses, industry and medical organizations. Additionally, the major area of initial focus will be genomics as it relates to prevention of infectious diseases. TCMC is creating a community-based clinical trials program supported by the development of a population-based genetic database. The College is pursuing research related to the health needs of the population, in which there is a prevalence of diabetes, cancer and heart disease.

The Principal Investigator of the Scranton EAGeR Study site is Anne Sweeney PhD. Dr. Sweeney was the first faculty member hired for the proposed medical school in October 2007. She is a Dunmore native and graduate Marywood University. She was a tenured Professor of Epidemiology at Texas A&M Health Science Center's School of Rural Public Health before returning to Scranton to join The Commonwealth Medical College.

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.